When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Rocky Mountain MS clinic, a Salt Lake City-based provider of specialized care for people living with multiple sclerosis, has ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market insights reveal exciting opportunities. See more.

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...